DI
REGN icon

Disciplined Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

Disciplined Investments’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-8
Closed -$5.75K – 1219
2023
Q2 		$5.75K Sell
8
-1
-11% -$771 ﹤0.01% 392
2023
Q1 		$7.39K Sell
9
-1
-10% -$754 ﹤0.01% 379
2022
Q4 		$7.21K Buy
10
+1
+11% +$738 ﹤0.01% 350
2022
Q3 		$6K Buy
9
+3
+50% +$1.89K ﹤0.01% 417
2022
Q2 		$4K Sell
6
-2
-25% -$1.3K ﹤0.01% 496
2022
Q1 		$6K Buy
+8
New +$5.06K ﹤0.01% 442

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Disciplined Investments's REGN Position: Q3 2023 in Review

Disciplined Investments sold out of Regeneron Pharmaceuticals (REGN) in Q3 2023, closing a stake of 8 shares — an estimated $5.75K sold.

Disciplined Investments first reported a position in REGN in Q1 2022 and held it in 6 quarters. The position peaked at $7.39K in Q1 2023. 1,177 funds tracked by Wall St. Rank hold REGN as of Q3 2023.

  • Disciplined Investments reported no remaining Regeneron Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Disciplined Investments sold 8 Regeneron Pharmaceuticals shares in Q3 2023, an estimated $5.75K.
  • Disciplined Investments first reported a position in Regeneron Pharmaceuticals in Q1 2022 and held it in 6 quarters.
  • Disciplined Investments's Regeneron Pharmaceuticals position peaked at $7.39K in Q1 2023.
  • 1,177 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2023.

Based on Disciplined Investments's 13F filing for Q3 2023, filed 14 Nov 2023.